Kazia Therapeutics Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +38.4% | +120.3% | -66.7% | +68.1% | -50.4% | +7.7% | -23.3% | +28.2% | -23.3% | -16.0% | -11.1% | -79.6% | -25.3% | -29.5% | -91.8% | +2.3% | +4,474.2% | +115.9% | -99.9% | -88.1% | +63,038.0% | +1,436.6% | -99.9% | -94.5% | +415,755.9% | -98.2% | |
| – | -77.6% | +1,318.1% | -92.5% | -5.5% | -34.1% | -1.6% | +17.2% | +27.6% | -41.2% | -38.3% | -12.2% | +489.7% | -21.6% | -100.4% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -313.4% | – | +114.5% | -54.9% | +11.5% | -37.8% | +28.6% | -11.3% | -6.1% | -10.8% | -73.7% | -25.3% | -26.5% | -92.2% | +2.3% | +4,474.2% | +115.9% | -99.9% | -88.1% | +63,038.0% | +1,436.6% | -99.9% | -94.5% | +415,755.9% | -98.2% | |
| – | +64.8% | -27.5% | +83.0% | +4.6% | -0.1% | +23.9% | +18.1% | +34.4% | +16.4% | -0.1% | -56.9% | -51.8% | +38.5% | -95.3% | +865.6% | +139.7% | +66.7% | +12.6% | -12.2% | -33.7% | +46.6% | +53.2% | +38.7% | -22.8% | +11.7% | -57.8% | |
| – | +3,500.7% | – | – | +21.1% | -43.7% | -5.3% | +22.6% | +15.7% | -23.6% | -58.9% | +55.8% | -8.0% | -39.5% | -50.8% | +49.7% | -9.9% | +49.9% | +48.0% | -34.4% | -32.4% | -2.5% | +90.3% | -27.2% | +67.9% | +58.0% | -35.7% | |
| – | +484.8% | – | – | +16.9% | -33.8% | +4.7% | +20.8% | +23.1% | -6.3% | -7.5% | -29.3% | -41.3% | -16.9% | -72.2% | +117.0% | +43.6% | +61.5% | +25.7% | -25.3% | -30.2% | +28.6% | +63.5% | +17.9% | -5.1% | +27.5% | -53.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -100.0% | – | -52.5% | -6.8% | -95.5% | +919.5% | -54.2% | +36.4% | +20.0% | -100.0% | – | +442.6% | -90.4% | -100.0% | – | -100.0% | – | -89.0% | +2,024.2% | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +170.0% | -24.5% | -116.7% | – | -97.8% | -48.6% | -187.5% | – | -76.1% | +900.0% | -90.0% | – | – | – | +50.7% | +92.7% | -107.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -178.8% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -223.9% | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.